UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

Value in health, 2019-01, Vol.22 (1), p.23-30

2019

Volltextzugriff (PDF)

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

Value in health, 2017-07, Vol.20 (7), p.945-952

2017

Volltextzugriff (PDF)

Transforming Latent Utilities to Health Utilities: East Does Not Meet West

Health economics, 2017-12, Vol.26 (12), p.1524-1533

2017

Volltextzugriff (PDF)

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

Dermatology and therapy, 2024-01, Vol.14 (1), p.169-182

2024

Volltextzugriff (PDF)

Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”

Dermatology and therapy, 2024-03, Vol.14 (3), p.823-827

2024

Volltextzugriff (PDF)

The EQ-5D-5L Valuation study in Thailand

Expert review of pharmacoeconomics & outcomes research, 2018-09, Vol.18 (5), p.551-558

2018

Volltextzugriff (PDF)

An exploration of methods for obtaining 0=dead anchors for latent scale EQ-5D-Y values

The European journal of health economics, 2020-09, Vol.21 (7), p.1091-1103

2020

Volltextzugriff (PDF)

The Indonesian EQ-5D-5L Value Set

PharmacoEconomics, 2017-11, Vol.35 (11), p.1153-1165

2017

Volltextzugriff (PDF)

Learning and Satisficing: An Analysis of Sequence Effects in Health Valuation

Value in health, 2015-03, Vol.18 (2), p.217-223

2015

Volltextzugriff (PDF)

Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Medical decision making, 2021-07, Vol.41 (5), p.584-596

2021

Volltextzugriff (PDF)

Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong

The patient : patient-centered outcomes research, 2018-04, Vol.11 (2), p.235-247

2018

Volltextzugriff (PDF)

Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication

The European journal of health economics, 2024-08, Vol.25 (6), p.1041-1055

2024

Volltextzugriff (PDF)

EQ-5D-Y Value Set for Germany

PharmacoEconomics, 2022-12, Vol.40 (Suppl 2), p.217-229

2022

Volltextzugriff (PDF)

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

Dermatology and therapy, 2024, Vol.14 (1), p.183-185

2024

Volltextzugriff (PDF)

Correction to: EQ-5D-Y Value Set for Germany

PharmacoEconomics, 2022-12, Vol.40 (Suppl 2), p.231-231

2022

Volltextzugriff (PDF)

Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy

Orphanet journal of rare diseases, 2019-06, Vol.14 (1), p.154-154, Article 154

2019

Volltextzugriff (PDF)

Patient information role in integrated health care

International journal of integrated care, 2019-08, Vol.19 (4), p.350

2019

Volltextzugriff (PDF)

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values

Health and quality of life outcomes, 2018-07, Vol.16 (1), p.152-152, Article 152

2018

Volltextzugriff (PDF)

Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models

Gaceta sanitaria, 2020-01, Vol.34 (1), p.91-95

2020

Volltextzugriff (PDF)

Eq5d: A command to Calculate Index Values for the EQ-5D Quality-of-life Instrument

The Stata journal, 2011-03, Vol.11 (1), p.120-125

2011

Volltextzugriff (PDF)

Métodos para la evaluación económica de programas de cribado neonatal

Revista española de salud pública, 2021 (95)

2021

Volltextzugriff (PDF)

Eq5dds: A Command to Analyze the Descriptive System of EQ-5D Quality-of-life Instrument

The Stata journal, 2016-09, Vol.16 (3), p.691-701

2016

Volltextzugriff (PDF)

An EQ-5D-5L value set based on Uruguayan population preferences

Quality of life research, 2016-02, Vol.25 (2), p.323-335

2016

Volltextzugriff (PDF)

A French Value Set for the EQ-5D-5L

PharmacoEconomics, 2020-04, Vol.38 (4), p.413-425

2020

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(30)
Health Care Sciences & Services
(24)
Health Policy & Services
(24)
Humans
(20)
Quality Of Life
(20)
Medicine
(18)
Medicine & Public Health
(17)
Social Sciences
(16)
Economics
(14)
Health Economics
(14)
Public Health
(14)
Business & Economics
(13)
Male
(13)
Quality Of Life Research
(13)
Valuation
(13)
Female
(12)
Pharmacoeconomics And Health Outcomes
(12)
Adult
(11)
Health Status
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

Transforming Latent Utilities to Health Utilities: East Does Not Meet West

Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

Response to “Letter to the Editor Regarding ‘Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Moderate to Severe Atopic Dermatitis’”

The EQ-5D-5L Valuation study in Thailand

An exploration of methods for obtaining 0=dead anchors for latent scale EQ-5D-Y values

The Indonesian EQ-5D-5L Value Set

Learning and Satisficing: An Analysis of Sequence Effects in Health Valuation

Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?

Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong

Cultural Values: Can They Explain Differences in Health Utilities between Countries?

Beyond 10-year lead-times in EQ-5D-5L: leveraging alternative lead-times in willingness-to-accept questions to capture preferences for worse-than-dead states and their implication

EQ-5D-Y Value Set for Germany

Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis

Correction to: EQ-5D-Y Value Set for Germany

Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy

Patient information role in integrated health care

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values

Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models

Eq5d: A command to Calculate Index Values for the EQ-5D Quality-of-life Instrument

Métodos para la evaluación económica de programas de cribado neonatal

Eq5dds: A Command to Analyze the Descriptive System of EQ-5D Quality-of-life Instrument

An EQ-5D-5L value set based on Uruguayan population preferences

A French Value Set for the EQ-5D-5L

Suchergebnisse filtern